Replay available

Medacta Group S.A. (0A05) Q2 2026 Earnings Call

Medacta Group S.A. (LSE: 0A05) Q2 2026 earnings conference call, held 2026-09-09. Replay captured from the company's public earnings webcast.

Wed, September 9, 2026 at 10:00 AMendedReplay
Medacta Group S.A. (0A05) Q2 2026 Earnings Call

Investor webinar replay

Meeting Overview The Medacta 1st Half 2026 Results Conference Call focused on the company's financial performance, highlighting a revenue growth of nearly 10% and a net profit of 42 million euros. The discussion also covered product innovations, market strategies, and the impact of geographic and product mix on profit margins. Key Discussion Points - Medacta reported a revenue of 368 million euros for H1 2026, with a net profit of 42 million euros. - The adjusted EBITDA margin was 27.8% in constant currency. - Growth was noted across various regions, with double-digit growth in three out of four regions. - Product performance included significant growth in hips (8%), knees (11%), extremities (16%), and spine (4.5%). - Innovations in the product line, including new technologies in hip and shoulder arthroplasty. - Discussion on the impact of geographic and product mix on gross profit margins. Decisions Made - Confirmed the 2026 outlook and midterm outlook for the company. Action Items...

Latest press releases

Companies on this event

Featured Presenters

Francesco Siccardi

CEO of Medacta

Corrado Farsetta

CFO of Medacta

Sam England

Analyst, Berenberg

Michelle Bushler

Analyst, ZKB

Graham Doyle

Analyst, UBS

Ed Hall

Analyst, TFL

Sandra Dici

Analyst, Octavian

Replay transcript excerpt

Speaker 1: Good afternoon. Speaker 1: This is the Corusco conference operator. Speaker 1: Welcome and thank you for joining the Medacta 1st 0.5 2026 Speaker 1: Results Conference Call. Speaker 1: As a reminder, Speaker 1: all participants are in listen-only mode. Speaker 1: After the presentation, Speaker 1: there will be an opportunity to ask questions. Speaker 1: At this time, I would like to turn the conference Speaker 1: over to Mr. Francesco Siccardi, Speaker 1: CEO of Medacta. Speaker 1: Please go ahead, sir. Speaker 2: Thank you very much and good afternoon or good morning. Speaker 2: Welcome to Medacta H1 Speaker 2: 2026 Speaker 2: results conference call. Speaker 2: So the slides of today's Speaker 2: presentation can be found on the Medacta Investor Speaker 2: Relations website along with the media release. Speaker 2: I would like to remind all participants Speaker 2: that the presentation Speaker 2: includes Speaker 2: forward-looking Speaker 2: statements Speaker 2: which are subject to risk and uncertainties. Speaker 2: Listeners and readers are therefore encouraged to refer to the disclaimer on slide 2 of today's presentation. Speaker 2: And after those housekeeping Speaker 2: remarks, I will now turn to slide Speaker 2: number 4 Speaker 2: and start with the highlights of today's Speaker 2: publication. Speaker 2: As already reported, Speaker 2: Medacta grew almost Speaker 2: 10% Speaker 2: in cost and currency in H1, Speaker 2: reaching 368 Speaker 2: million Speaker 2: Euro in terms of revenues. Speaker 2: We managed to report an adjusted ABDA margin Speaker 2: of 27.8% Speaker 2: in constant currency, Speaker 2: or 26.5% Speaker 2: reported, Speaker 2: equivalent to adjusted EBDA of 97 Speaker 2: million euro. Speaker 2: The net profit for the perio...

More from Medacta Group Sa